Spring Time Itch Relief From Apoquel
Now that the longer, warmer days of spring are with us, veterinary practices are likely to see an increase in cases of canine pruritus as dogs are more exposed to common allergens such as pollen, dust mites and flea bites.
With the higher numbers of itchy dogs visiting veterinary clinics, Zoetis is anticipating an increase in demand for Apoquel. To support practices and ensure they have sufficient product in stock to meet the needs of their itchy canine patients, Zoetis is running a spring Apoquel offer.
Apoquel is a fast-acting oral therapy for the treatment of canine pruritus associated with allergic dermatitis. Its novel mechanism of action on the Janus Kinase (JAK) enzyme is specifically designed to target the pruritogenic and pro-inflammatory pathways involved in the itch cycle. This allows effective reduction of allergic itch regardless of its cause as well as improvement of skin lesions associated with allergic skin diseases and atopic dermatitis.
For more information about the Apoquel Spring offer please contact your Zoetis account manager.
More from Zoetis
- Zoetis appoints new Inside Sales Account Manager
- Zoetis Equip® Artervac Supply Issue
- Zoetis UK Appoints Simon Dunne as Companion Animal Business Unit Director
- Zoetis UK: Update On The Supply Of Equip® Rotavirus
- Zoetis UK and StreetVet Announce Charity of the Year Partnership to Further Support the Human Animal Bond